Healthcare & Life Sciences
Nuevocor
Singaporewww.nuevocor.com/
Nuevocor is a series a startup based in Singapore. 1 investor tracked.
series-b
series-b
Stage
2023
Founded
2
Investors
About Nuevocor
Nuevocor is a company founded in 2023 headquartered in Singapore. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Nuevocor is a biotechnology company developing mechanobiology-centered, pathway-specific genetic medicines to treat cardiomyopathies. Its pipeline includes AAV-based gene therapy candidates such as NVC-001 for LMNA-related dilated cardiomyopathy and other preclinical and clinical programs.
Explore Nuevocor's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.